BioCentury
ARTICLE | Finance

JMP's Kingmaker

JPM adds biotech analyst Mike King; readies challenge to middle market banks

January 14, 2013 8:00 AM UTC

Longtime analyst Mike King joined JMP Securities last month to beef up the bank's research team as it looks to compete with the likes of Cowen, Leerink, Lazard and Stifel Nicolaus Weisel.

This is the second move King has made in a few months...